No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Adult
-
Aged
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Child
-
Female
-
Humans
-
Infliximab
-
Infusions, Intravenous
-
Male
-
Middle Aged
-
Prospective Studies
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Uveitis / drug therapy*
-
Young Adult
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Tumor Necrosis Factor-alpha
-
Infliximab
Associated data
-
ClinicalTrials.gov/NCT00273390